Specifically, the amyloid-β (Aβ) 1–42, the aberrant protein aggregation contributes to the pathogenesis of Alzheimer’s disease (AD), reduces astrocyte viability while increasing the expression of TNF-α, IL-1β, COX-2, and iNOS. This evidence concerns the gene PTGS2 and Alzheimer disease.